Zobrazeno 1 - 10
of 15
pro vyhledávání: '"N. A. Rodriguez-Jimenez"'
Autor:
A. Martinez-Hernandez, E. E. Perez-Guerrero, M. A. Macias-Islas, C. A. Nava-Valdivia, A. Villagomez-Vega, B. Contreras-Haro, Y. E. Garcia-Ortega, Y. Esparza-Guerrero, S. G. Gallardo-Moya, J. I. Gamez-Nava, L. Gonzalez-Lopez, E. Oliva-Flores, N. A. Rodriguez-Jimenez, F. Cortes-Enriquez, A. M. Saldaña-Cruz
Publikováno v:
Journal of Immunology Research, Vol 2021 (2021)
Background. Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease. Low vitamin D levels have been reported to be a risk factor for MS, and genetic variances could be implicated. The aim of this study was to evaluate the association of
Externí odkaz:
https://doaj.org/article/da1d67fb60f34cd88e9db4a09a7ed620
Autor:
Valeria Diaz-Rizo, David Bonilla-Lara, Laura Gonzalez-Lopez, Dalia Sanchez-Mosco, Nicte S Fajardo-Robledo, Edsaul E Perez-Guerrero, N Alejandra Rodriguez-Jimenez, A Miriam Saldaña-Cruz, M Luisa Vazquez-Villegas, Eduardo Gomez-Bañuelos, Monica Vazquez-Del Mercado, E German Cardona-Muñoz, David Cardona-Muller, Xochitl Trujillo, Miguel Huerta, Mario Salazar-Paramo, Jorge I Gamez-Nava
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184056 (2017)
There are controversial results about the role of serum leptin and adiponectin levels as biomarkers of the severity of proteinuria in lupus nephritis.The aim of this study was to evaluate the relationship between serum leptin and adiponectin levels w
Externí odkaz:
https://doaj.org/article/d6f69041a206431d899cdaf1007b74eb
Autor:
Nicte S, Fajardo-Robledo, Heriberto, Jacobo-Cuevas, Edsaul E, Perez-Guerrero, Esther G, Corona-Sanchez, A Miriam, Saldaña-Cruz, Elba M, Romero-Tejeda, N Alejandra, Rodriguez-Jimenez, Sylvia E, Totsuka-Sutto, Rocio I, Lopez-Roa, Juan M, Ponce-Guarneros, M Fabiola, Alcaraz-Lopez, Sergio, Cerpa-Cruz, J Francisco, Muñoz-Valle, E German, Cardona-Muñoz, Laura, Gonzalez-Lopez, Jorge I, Gamez-Nava, Jorge Ivan, Gamez-Nava
Publikováno v:
Scientific Reports
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
There is a significant rate of therapeutic failure in rheumatoid arthritis (RA) patients treated with leflunomide (LEF). This study investigates the utility values of teriflunomide levels (A77 1726) in identifying RA patients who remained with modera
Autor:
Melissa Ramirez-Villafaña, N Alejandra Rodriguez-Jimenez, Jorge I Gamez-Nava, Javier A Aceves-Aceves, Ana M Saldaña-Cruz, Ernesto G. Cardona-Muñoz, Sylvia E Totsuka-Sutto, J Manuel Ponce-Guarneros, Fidencio Cons-Molina, Xochitl Trujillo, Miguel Huerta, Alfonso J Cruz-Jentoft, Laura Gonzalez-Lopez
Background Low muscle mass (myopenia) is frequent in rheumatoid arthritis (RA) patients with a long-disease duration. Although, the use of combined therapy with conventional synthetic DMARDs (csDMARDs) is one of the main strategies observed in these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f2befad4c85690477a2fe7255e12be8
https://doi.org/10.21203/rs.3.rs-25713/v1
https://doi.org/10.21203/rs.3.rs-25713/v1
Autor:
Jorge I. Gamez-Nava, Esther N Sanchez-Rodriguez, José Francisco Muñoz-Valle, Sergio Ramón Gutiérrez-Ureña, José Clemente Vásquez-Jiménez, Sergio Cerpa-Cruz, N. A. Rodriguez-Jimenez, Erika Anita Aguilar-Chavez, M. L. Vazquez-Villegas, Laura Gonzalez-Lopez, Edsaul Emilio Perez-Guerrero, Ana Miriam Saldaña-Cruz, N. S. Fajardo-Robledo, Ernesto Germán Cardona-Muñoz, M. Ramirez-Villafaña
Publikováno v:
Inflammopharmacology. 26:1375-1381
To evaluate the utility of elevated serum P-glycoprotein (P-gp) as a risk marker of therapeutic response failure in rheumatoid arthritis (RA) patients treated with disease-modifying antirheumatic drugs (DMARDs). A cross-sectional study was conducted
Autor:
Jorge I. Gamez-Nava, N. Alejandra Rodriguez-Jimenez, Laura Gonzalez-Lopez, Edsaul Emilio Perez-Guerrero, Itzel Nayar Becerra-Alvarado, Fabiola González-Ponce, J. Alejandro Zuñiga-Mora, Erika Y. Vera-Navarrete, J. D. Murillo-Vazquez, A. Miriam Saldaña-Cruz, M. Luisa Vazquez-Villegas, J. M. Ponce-Guarneros, David Bonilla-Lara
Publikováno v:
Innate Immunity. 23:606-614
The objective of this study was to investigate the usefulness of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in predicting short-term therapeutic response to methotrexate (MTX) in rheumatoid arthritis (RA). Patients with active
Autor:
Alberto Daniel Rocha-Muñoz, M. L. Vazquez-Villegas, N. A. Rodriguez-Jimenez, J. Francisco Muñoz-Valle, Paulina Hernández-Cuervo, S. A. Zavaleta-Muñiz, Ernesto Germán Cardona-Muñoz, N. S. Fajardo-Robledo, Inocente V. Moreno-Sandoval, A. Miriam Saldaña-Cruz, David Bonilla-Lara, Jorge I. Gamez-Nava, Mario Salazar-Páramo, Laura Gonzalez-Lopez, Arnulfo Hernán Nava-Zavala
Publikováno v:
The Journal of International Medical Research
Objective To identify correlations of the serum leptin, adiponectin, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) concentrations with the clinical characteristics, presence of spinal syndesmophytes, and body composition in patients wit
Autor:
Laura Gonzalez-Lopez, Edsaul Emilio Perez-Guerrero, N. A. Rodriguez-Jimenez, Ernesto Germán Cardona-Muñoz, Jorge I. Gamez-Nava, Mario Salazar-Páramo, Arnulfo Hernán Nava-Zavala, M Ponce-Guarneros, Teresa Arcelia Garcia-Cobian, EY Vera-Navarrete
Publikováno v:
Poster Presentations.
Background Syndecans includes a group of proteins from the cell-surface heparan-sulfate proteoglycan family, with a relevant role in chronic inflammation of synovial tissue in patients with rheumatoid arthritis (RA) participating in the cell-matrix a
Autor:
E. G. Corona-Sanchez, A. Celis-De La Rosa, B T Martín-Márquez, Carlos Enrique Cabrera-Pivaral, EM Olivas-Flores, M. L. Vazquez-Villegas, Norma Guadalupe Gonzalez-Montoya, Jorge I. Gamez-Nava, José Francisco Muñoz-Valle, Alberto Daniel Rocha-Muñoz, S. A. Zavaleta-Muñiz, M. E. Martinez-Corral, Ernesto Germán Cardona-Muñoz, N. A. Rodriguez-Jimenez, M Vázquez-Del Mercado, Laura Gonzalez-Lopez, A. Vega-Lopez
Publikováno v:
Rheumatology International. 33:145-150
Glucocorticoids are frequently used in rheumatoid arthritis (RA) in order to alleviate symptoms of joint inflammation, retard erosions and to treat extra-articular manifestations, although these drugs may increase the risk of bone mineral loss and os
Autor:
María Guadalupe Zavala-Cerna, N. A. Rodriguez-Jimenez, José Clemente Vásquez-Jiménez, Arnulfo Hernán Nava-Zavala, Jorge I. Gamez-Nava, Mario Salazar-Páramo, Valeria Diaz-Rizo, Aniel Jessica Leticia Brambila-Tapia, Mónica Vázquez-Del Mercado, Ernesto Germán Cardona-Muñoz, Alberto Daniel Rocha-Muñoz, Ingrid Patricia Dávalos-Rodríguez, Laura Gonzalez-Lopez, Liliana Faviola De la Cerda-Trujillo, Viviana Díaz-González
Publikováno v:
Journal of Immunology Research, Vol 2015 (2015)
Journal of Immunology Research
Journal of Immunology Research
Objective. To evaluate the effect of anti-TNF agents plus synthetic disease modifying antirheumatic drugs (DMARDs) versus DMARDs alone for ankylosing spondylitis (AS) with reduced pulmonary function vital capacity (FVC%).Methods. In an observational